Cleavage of beta 4 integrin by matrilysin

Exp Cell Res. 1997 Oct 10;236(1):341-5. doi: 10.1006/excr.1997.3711.

Abstract

Overexpression of the matrix metalloproteinase matrilysin and the absence of beta 4 integrin are two features characteristic of human prostate carcinoma. In the following study we demonstrate that the beta 4 integrin, but not the alpha 6 or beta 1 integrin subunits, is cleaved by matrilysin in vitro. A specific fragment of 90 kDa is generated using matrilysin, which is not observed with other proteases. Two putative cleavage sites for matrilysin within the extracellular domain of the beta 4 integrin at residues 107 (isoleucine, prior to the ligand-binding region) and 417 (leucine, prior to cysteine-rich region) are identified by sequence comparisons with known matrilysin substrates. The selective cleavage of the beta 4 integrin by matrilysin may partly explain the loss of beta 4 integrin expression in invasive prostate carcinoma.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, CD / chemistry
  • Antigens, CD / metabolism*
  • Antigens, Surface / metabolism
  • Calpain / metabolism
  • Calpain / pharmacology
  • Extracellular Matrix Proteins / metabolism
  • Extracellular Matrix Proteins / pharmacology
  • Humans
  • Integrin beta4
  • Integrins / metabolism
  • Male
  • Matrix Metalloproteinase 7
  • Metalloendopeptidases / metabolism*
  • Metalloendopeptidases / pharmacology*
  • Prostatic Neoplasms*
  • Protein Structure, Tertiary
  • Substrate Specificity
  • Trypsin / metabolism
  • Trypsin / pharmacology
  • Tumor Cells, Cultured / chemistry
  • Tumor Cells, Cultured / enzymology

Substances

  • Antigens, CD
  • Antigens, Surface
  • Extracellular Matrix Proteins
  • Integrin beta4
  • Integrins
  • Trypsin
  • Calpain
  • Metalloendopeptidases
  • Matrix Metalloproteinase 7